Cancer feature: cnaPANCAN130

ABCB8 ABCF2 AC005481.5 AC008060.7 AC009403.2 AC021218.2 AC099552.4 ACTR3B ACTR3C AGAP3 AOC1 ASB10 ASIC3 ATG9B ATP6V0E2 BLACE C7orf13 CDK5 CHPF2 CNPY1 CRYGN DNAJB6 DPP6 EN2 FASTK GALNT11 GALNTL5 GBX1 GIMAP1 GIMAP2 GIMAP4 GIMAP5 GIMAP6 GIMAP7 GIMAP8 HTR5A HTR5A-AS1 INSIG1 KCNH2 KMT2C KRBA1 LMBR1 LRRC61 MNX1 NOM1 NOS3 NUB1 PAXIP1 PAXIP1-AS2 PRKAG2 PTPRN2 RARRES2 RBM33 REPIN1 RHEB RNF32 SHH SLC4A2 SMARCD3 TMEM176A TMEM176B TMUB1 UBE3C WDR86 XRCC2 ZBED6CL ZNF212 ZNF282 ZNF467 ZNF746 ZNF775 ZNF777 ZNF783 ZNF862

Known Driver Genes: None

Copy number alternation: gain

Daporinad

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer